Profound Medical (PROF) Invested Capital (2018 - 2026)

Profound Medical (PROF) posted quarterly Invested Capital of $4.5 million for Q1 2026, up 0.51% quarter-over-quarter from $4.5 million in Q3 2025.

Profound Medical (PROF) Invested Capital (2018 - 2026) Analysis & Trends

Profound Medical's Invested Capital history runs 9 years deep, the most recent figure standing at $4.5 million for Q1 2026.

In Q1 2026, Invested Capital changed N/A year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $9.0 million (up 417.16% YoY), while the FY2024 annual figure was $1.7 million, up 107.53% from the prior year.
Invested Capital for Q1 2026 stood at $4.5 million, up from $4.5 million in the prior quarter.
The five-year high for Invested Capital was $7.2 million in Q4 2022, with the low at $837000.0 in Q4 2023.
The 5-year median for Invested Capital is $4.5 million (2025), against an average of $3.7 million.
The sharpest annual moves came in 2022 and 2023: Invested Capital soared 420.99% in 2022, then tumbled 88.33% in 2023.
Profound Medical's Invested Capital stood at $7.2 million in 2022, then sank by 88.33% to $837000.0 in 2023, then jumped by 107.53% to $1.7 million in 2024, then surged by 157.92% to $4.5 million in 2025, then grew by 0.51% to $4.5 million in 2026.
Business Quant data shows PROF's Invested Capital at $4.5 million in Q1 2026, $4.5 million in Q3 2025, and $1.7 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	3.01 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	1.34 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	243.40 Mn
10	Profound Medical	241.00 Mn	202.73 Mn	1.95 Mn	4.51 Mn

Download Data